Oral Vinorelbine and Cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral Vinorelbine and Cispalatine plus best supportive care or best supportive care alone in stage III Non Small Cell Lung Cancer (NSCLC): rand
Oral Vinorelbine and Cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral Vinorelbine and Cispalatine plus best supportive care or best supportive care alone in stage III Non Small Cell Lung Cancer (NSCLC): rand
Oral Vinorelbine and Cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral Vinorelbine and Cispalatine plus best supportive care or best supportive care alone in stage III Non Small Cell Lung Cancer (NSCLC): randomized Phase III study
Status
Status :
Early termination
Type of study
Phase III
Min. Age
18
Years old
Max. Age
75
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Non small cell lung cancer (NSCLC)
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase III
Start Date :
02 May 2005
End date :
09 May 2012
Study ID :
PM0259 CA 304 J1
EudraCT/CTIS number :
2004-005135-26
Send by email